- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Dopamine Release
Total 8537 results
-
Boehringer IngelheimCompletedParkinson DiseaseUnited States
-
Janssen Korea, Ltd., KoreaCompletedAttention Deficit Disorder With Hyperactivity
-
Janssen Korea, Ltd., KoreaCompletedSchizophreniaKorea, Republic of
-
Janssen-Cilag G.m.b.HTerminated
-
Johnson & Johnson Taiwan LtdCompleted
-
Johnson & Johnson Taiwan LtdCompleted
-
Johnson & Johnson Taiwan LtdCompleted
-
Forest LaboratoriesMerz Pharmaceuticals GmbHCompleted
-
Janssen-Cilag Farmaceutica Ltda.Completed
-
Massachusetts General HospitalMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.Completed
-
Janssen-Cilag TurkeyCompleted
-
Duke UniversityNational Institute of Mental Health (NIMH)CompletedAttention Deficit Disorder With HyperactivityUnited States
-
Seoul National University HospitalCompletedParkinson DiseaseKorea, Republic of
-
Janssen Korea, Ltd., KoreaCompletedAttention Deficit Disorder With Hyperactivity
-
Xian-Janssen Pharmaceutical Ltd.Completed
-
Janssen-Cilag International NVCompletedSchizophreniaPoland, Israel, Romania, Germany, Lithuania, Croatia, France
-
Boston Children's HospitalNational Institute of Mental Health (NIMH)CompletedEpilepsy | Attention Deficit Disorder With HyperactivityUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen, LPCompletedSchizoaffective Disorder | Psychotic Disorder
-
Janssen Research & Development, LLCCompletedSchizophreniaUkraine, United States, Spain, India, Romania, Russian Federation, Slovakia
-
Janssen-Cilag S.p.A.Completed
-
The University of Texas Health Science Center,...National Institute of Mental Health (NIMH)CompletedAutism | Attention Deficit Disorder With HyperactivityUnited States
-
GlaxoSmithKlineCompleted
-
Janssen-Cilag, S.A.CompletedSchizophreniaColombia, Argentina
-
Centre for Addiction and Mental HealthPfizerCompleted
-
Janssen-Cilag Ltd.,ThailandCompleted
-
GlaxoSmithKlineCompletedAttention Deficit DisorderUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Eli Lilly and CompanyTerminatedAttention Deficit Hyperactivity DisorderNetherlands, Sweden, Spain
-
Chonbuk National University HospitalAstraZeneca; Sanofi-Synthelabo; Janssen Korea, Ltd., Korea; Korea Otsuka Pharmaceutical...CompletedSchizophreniaKorea, Republic of
-
Janssen PharmaceuticaCompleted
-
Janssen Pharmaceutical K.K.Completed
-
University of CincinnatiNational Institute on Drug Abuse (NIDA); Ortho-McNeil Janssen Scientific Affairs...CompletedSmoking | ADHDUnited States
-
Rajesh Pahwa, MDGlaxoSmithKlineCompleted
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
Novartis PharmaceuticalsCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Novartis PharmaceuticalsOrion Corporation, Orion PharmaCompletedParkinson's DiseaseUnited States, Switzerland, Germany, Finland, Greece, Italy, Spain, United Kingdom, Canada, France, Turkey, Belgium, Sweden, Austria
-
Hadassah Medical OrganizationUnknownTobacco Use DisorderIsrael
-
PfizerCompletedDepressive Disorder, MajorUnited States
-
Chonnam National University HospitalJanssen Korea, Ltd., Korea; Ministry of Health, Republic of KoreaCompletedSchizophreniaKorea, Republic of
-
Children's Hospital of PhiladelphiaOrtho-McNeil Janssen Scientific Affairs, LLCCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Chi-Un PaeGlaxoSmithKlineCompletedDepressive Disorder, MajorKorea, Republic of
-
PfizerCompletedPharmacokinetics | Cytochrome P-450 CYP2D6 | CYP3A4 Protein, HumanUnited States
-
Massachusetts General HospitalMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.Completed
-
Massachusetts General HospitalMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedMood Disorders | Bipolar Disorder
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedSchizophrenia | Schizoaffective Disorder